CLTI Prognosis and Chronic Limb-Threatening Ischemia Outcomes: Scoping Review with ☸️SAIMSARA
SAIMSARA Journal · 03.05.2026 · 1 (1)
DOI: 10.62487/saimsara9e1c0fc3 ↗Kurz gefasst
Scoping Review in der Zeitschrift SAIMSARA Journal, online erschienen am 03.05.2026. Die Arbeit nennt 69 Literaturangaben.
Abstract (Originalsprache)
The aim of this review is to synthesize contemporary evidence regarding the prognostic factors, clinical scoring systems, and long-term outcomes for patients diagnosed with CLTI (Chronic Limb-Threatening Ischemia). The review utilises 74 original studies with 392683 total participants (topic deduplicated ΣN). The mapped evidence indicates that prognosis in CLTI is shaped less by any single anatomical feature and more by the convergence of wound severity, nutritional state, and systemic frailty, with 5-year amputation-free survival ranging from 26.5%–35.4% in high-risk groups to 72.1%–89.5% in low-risk groups. The Wound, Ischemia, and foot Infection (WIfI) classification and nutritional indices such as the Geriatric Nutritional Risk Index, Prognostic Nutritional Index, and Controlling Nutritional Status score emerged as the most recurrent independent predictors across cohorts, while revascularization was associated with improved 1-year amputation-free survival (58.0% versus 45.7% in tissue-loss disease). Recurrent secondary signals included hemodialysis, heart failure with reduced ejection fraction (2-year amputation-free survival 35% versus 61% in preserved ejection fraction), ambulatory decline (1-year survival 86.8% versus 23.9%), calcification burden, depression, and emerging inflammatory, microRNA, and metabolomic biomarkers, suggesting that prognosis is best understood as a multidomain construct rather than a purely vascular one. Clinically, this supports embedding combined wound, nutritional, frailty, and cardiac assessment into routine pre-revascularization workup to identify patients who may benefit from intensified medical optimization or alternative care pathways. The evidence map is, however, dominated by retrospective single-region cohorts with heterogeneous endpoints, which tempers certainty about the relative weight of individual predictors. Future research should prioritize prospective multicenter validation of composite prognostic scores integrating WIfI stage, nutritional indices, frailty, and novel biomarkers, alongside interventional trials testing whether modifying nutrition, depression, or ambulatory decline translates into measurable gains in amputation-free survival.
Zitieren
APA
(2026). CLTI Prognosis and Chronic Limb-Threatening Ischemia Outcomes: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal, 1(1). https://doi.org/10.62487/saimsara9e1c0fc3
Vancouver
CLTI Prognosis and Chronic Limb-Threatening Ischemia Outcomes: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal. 2026;1(1). doi:10.62487/saimsara9e1c0fc3
BibTeX
@article{euvimed2026,
title = {CLTI Prognosis and Chronic Limb-Threatening Ischemia Outcomes: Scoping Review with ☸️SAIMSARA},
journal = {SAIMSARA Journal},
year = {2026},
volume = {1},
number = {1},
doi = {10.62487/saimsara9e1c0fc3}
}
EUVIMED